BGF-backed software firm Skewb has made its first corporate acquisition with the purchase of Clear Horizon IS, bringing it into the UK power sector for the first time. The Warwick-based firm, which ...
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The prize pool for this year’s Apex Legends Global Championship ...
The final session of the ALGS Year 6 Split 1 Group Stage is underway Thursday at Paris Expo Porte de Versailles, where 40 international trios are completing their 18th and final game. By the time the ...
Florida and the desolate Sahara don’t have a lot in common. However, this time of year, they’re linked by a remarkable weather pattern that carries vast plumes of Saharan dust some 6,000 miles across ...
Abrupt shifts within complex systems such as the Earth's climate system are extremely hard to predict. Researchers have now succeeded in developing a new method to anticipate such tipping points in ...
TAMPA, Fla. — A plume of dust from the Sahara Desert is floating into Florida, and it’s already making its mark on the Tampa Bay-area forecast. These recurring summer events, known as Saharan Air ...
Texas is set to be hit by a wave of Saharan dust this week. North Texans should get ready for hazy skies this week, as Saharan dust descends on the Dallas-Fort Worth area. While the dust over North ...
Western Sahara has been on the United Nations list of Non-Self-Governing Territories since 1963 following the transmission of information on Spanish Sahara by Spain under Article 73 e of the Charter ...
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the ...
Aligos Therapeutics Inc. shares are trending overnight after the company announced a licensing milestone and regulatory progress for its chronic hepatitis B treatment candidate in China. Aligos closed ...
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the ...